medigraphic.com
Colegio de Medicina Interna de México.

2024, Number 9

<< Back Next >>

Med Int Mex 2024; 40 (9)

Spontaneous pneumomediastinum, a potentially mortal complication in SARSCoV- 2 pneumonia: a five-case-series

Ortiz PS

Language: Spanish
References: 20
Page: 621-630
PDF size: 1088.03 Kb.


ABSTRACT

Background: Spontaneous pneumomediastinum is an unusual pulmonary complication of SARS-CoV-2 pneumonia. It is mostly described as a benign finding with spontaneous resolution. Some authors mention that cases with adverse outcomes (increased mortality) have been reported. Clinical experience shows a similar trend; therefore, the scientific evidence is equivocal; hence the need to document what happened in the pandemic.
Clinical cases: Five clinical cases of hospitalized patients aged 39 and 76 years with the following risk factors are described: smoking, asthma, chronic obstructive pulmonary disease, and obesity. Diagnosis was made by chest computed tomography and physical examination.
Conclusions: Spontaneous pneumomediastinum is a complication associated with increased severity and mortality in COVID-19. A systematic review with a higher level of evidence is needed to update clinical care guidelines and reduce morbidity and mortality in COVID-19.


REFERENCES

  1. Parra ML, et al. Aspectos radiológicos de la neumoníaCOVID-19: evolución y complicaciones torácicas Radiología 2021; 63 (1): 74–88. https://doi.org/10.1016/j.rx.2020.11.002

  2. Kolani S, Houari N, Haloua M, et al. Spontaneous pneumomediastinumoccurring in the SARS-COV-2 infection. IDCases2020; 21. https://doi.org/10.1016/j.idcr.2020.e00806

  3. Pérez-López KP, Moreno-Madrigal LG. Neumotórax y neumomediastinoespontáneos en pacientes con neumoníapor COVID-19. Med Int Méx 2021; 37 (1): 152-56. https://doi.org/10.24245/mim. v37i1.4755

  4. Aguado-Aguado M, Bielsa-Masdeu AM, Kurtz-Cabello M,et al. Incidencia de neumomediastino en los pacientesingresados con COVID-19 en un hospital de tercer nivel.Revista de Medicina Clínica 2021; 05 (02). https://doi.org/10.5281/zenodo.4732321

  5. Primelles D, et al. Neumomediastino secundario a efectoMacklin: presentación de caso. Rev. Med. Electrón 2011;33 (5): 606-13. http://scielo.sld.cu/scielo.php?script=sci_arttext&pid=S1684-18242011000500006&lng=es&nrm=iso>

  6. Hasegawa M, et al. Spontaneous pneumomediastinumcomplicating pneumonia in children infected with the2009 pandemic influenza A (H1N1) virus. Clin MicrobiolInfect 2010; 16: 195-99. https://doi.org/ 10.1111/j.1469-0691.2009.03086.x

  7. Luis BAL Navarro AO, Palacios GMR. Pneumomediastinumand subcutaneous emphysema associated with influenzaA H1N1 virus. Lancet Infect Dis 2017; 17: 671. https://doi.org/10.1016/S1473-3099(17)30262-1

  8. Bolaños-Morales FV, Santibáñez-Salgado J, Guadarrama-Pérez C, et al. Neumomediastino espontáneo en pacientesCOVID-19. Serie de casos. Gac Méd Méx 2021; 157 (1):116-20. https://doi.org/10.24875/gmm.2000089

  9. López JM, Parra ML, Díez A, Ossaba S. Pneumomediastinumand spontaneous pneumothorax as an extrapulmonarycomplication of COVID-19 disease. Emerg Radiol 2020; 27:727–730. https://doi.org/10.1007/s10140-020-01806-0

  10. Gil-Vargas M, González-Rodríguez LE, León-Aguilar VH.Neumomediastino secundario a efecto Macklin. Reportede un caso. Acta Pediátrica de México 2017; 38 (5): 317-21. https://doi.org/10.18233/apm38no5pp317-3211471

  11. Jacqmin G, Pirotte M, Caravaggio C, Devaux P. Spontaneouspneumomediastinum: a possible severe condition inSARS-CoV-2 pneumonia. Thorac Cardiovasc Surg Rep 2021;10 (1). https://doi.org/10.1055/s-0041-1735478

  12. OPS-OMS. Organización Panamericana de la Salud-OrganizaciónMundial de la Salud. Guía para el cuidado críticode pacientes adultos graves con coronavirus (COVID-19) enlas américas. Versión Larga -V1, Abril 29, 2022.

  13. Massachusetts General Hospital, COVID-19 TreatmentGuidance, Versión 1.0, March 17, 2020. https://doi.org/10.1136/thorax.56.4.296

  14. Alhazzani W, Møller MH, Arabi YM, Loeb M, et al. Survivingsepsis campaign: guidelines on the management of criticallyill adults with coronavirus disease 2019 (COVID-19).Crit Care Med 2020. https://doi.org/10.1007/s00134-020-06022-5

  15. Zhou C, et al. COVID-19 with spontaneous pneumomediastinum.Lancet Infect Dis 2020; 20 (4): 510. https://doi.org/10.1016/S1473-3099(20)30156-0

  16. Varela M, Torres B. Neumomediastino y enfisema subcutáneoen relación con la pandemia por SARS-CoV-2. Med GenFam digital 2020; 9: 162-64. http://dx.doi.org/10.24038/mgyf.2020.026

  17. Gorospe L, Ayala-Carbonero A, Ureña-Vacas A, et al. Neumomediastinoespontáneo en pacientes con COVID-19:una serie de cuatro casos. Arch Bronconeumol 2020; 56:754-56. https://doi.org/10.1016/j.arbres.2020.06.008

  18. Chu CM, Leung YY, Hui JY, et al. Spontaneous pneumomediastinumin patients with severe acute respiratorysyndrome. European Respiratory Journal 2004; 23 (6):802-04. https://doi.org/10.1183/09031936.04.00096404

  19. Tacconi F, Rogliani P, Leonardis F, et al. Incidence ofpneumomediastinum in COVID-19: A single-center comparisonbetween 1st and 2dn wave. Respiratory Investigation 2021; 59 (5): 661-65. https://doi.org/10.1016/j.resinv.2021.04.010

  20. Prompetchara E, Ketloy C, Palaga T. Immune responses inCOVID-19 and potential vaccines: lessons learned fromSARS and MERS epidemic. Asian Pac J Allergy Immunol2020; 38: 1-9. https://doi.org/10.12932/AP-200220




2020     |     www.medigraphic.com